Welcome to the Cancer Diagnosis Program
The Cancer Diagnosis Program (CDP) strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, co-ordinates and funds resources and research on diagnostics and improved technologies to better characterize cancers to guide the choice of treatment as well as to evaluate the response to treatment.
Program for the Assessment of Clinical Cancer Tests (PACCT)
The PACCT has been developed to ensure that development of the next generation of laboratory tests is efficient and effective. The implementation of this program is based on the need to address identified barriers to development. New components of the program will be developed as needed. More…
Strategic Partnering to Evaluate Cancer Signatures (SPECS)
The goals of the SPECS programs are: To translate molecular signatures/profiles derived from comprehensive molecular analysis of tumors to improved patient management and ultimately improved patient outcomes; To establish strategic partnerships that bring together the interdisciplinary teams needed to evaluate the potential clinical utility of molecular signatures. More…
